BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities. World J Gastroenterol 2014; 20(18): 5320-5330 [PMID: 24833862 DOI: 10.3748/wjg.v20.i18.5320]
URL: https://www.wjgnet.com/1948-5182/full/v20/i18/5320.htm
Number Citing Articles
1
Qian Yu, Yann-yin Lee, Zheng-yun Xia, Emily C. Liong, Jia Xiao, George L. Tipoe. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammationEuropean Journal of Nutrition 2021; 60(2): 961 doi: 10.1007/s00394-020-02305-1
2
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
3
Fumin Li, Christopher Cousineau, Gang Xing, Nancy Raha, Sara Clemens, Melissa Mofikoya, Moo-Young Kim, Jenny Yanhua Zhang. Development and validation of a quantitative ultra performance LC® hydrophilic interaction liquid chromatography MS/MS method to measure fructose and sorbitol in human plasmaBioanalysis 2019; 11(5): 407 doi: 10.4155/bio-2018-0286
4
Karim Gariani, Keir J. Menzies, Dongryeol Ryu, Casey J. Wegner, Xu Wang, Eduardo R. Ropelle, Norman Moullan, Hongbo Zhang, Alessia Perino, Vera Lemos, Bohkyung Kim, Young‐Ki Park, Alessandra Piersigilli, Tho X. Pham, Yue Yang, Chai Siah Ku, Sung I. Koo, Anna Fomitchova, Carlos Cantó, Kristina Schoonjans, Anthony A. Sauve, Ji‐Young Lee, Johan Auwerx. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in miceHepatology 2016; 63(4): 1190 doi: 10.1002/hep.28245
5
Marta Iruarrizaga-Lejarreta, Enara Arretxe, Cristina Alonso. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitisExpert Review of Precision Medicine and Drug Development 2019; 4(5): 283 doi: 10.1080/23808993.2019.1685379
6
Péter Jenö Hegyi, Alexandra Soós, Péter Hegyi, Zsolt Szakács, Lilla Hanák, Szilárd Váncsa, Klementina Ocskay, Erika Pétervári, Márta Balaskó, Bálint Eröss, Gabriella Pár. Pre-transplant Sarcopenic Obesity Worsens the Survival After Liver Transplantation: A Meta-Analysis and a Systematic ReviewFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.599434
7
Paul N. Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, Rohit Loomba, Derek A. Mann, Jonathan A. Fallowfield. Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approachNature Reviews Gastroenterology & Hepatology 2023; 20(10): 679 doi: 10.1038/s41575-023-00796-x
8
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging TherapiesLivers 2023; 3(4): 637 doi: 10.3390/livers3040042
9
Birnur Yılmaz, Özgür Kürşat Şener, Halime Çevik. Shear Wave Velocity results of non-alcoholic fatty liver disease in diabetic patientsJournal of Surgery and Medicine 2018;  doi: 10.28982/josam.435189
10
Piper Sandel, Lawrence Ma, Helen Wang, Eric A. Pasman. You Are What You Eat: A Review on Dietary Interventions for Treating Pediatric Nonalcoholic Fatty Liver DiseaseNutrients 2023; 15(15): 3350 doi: 10.3390/nu15153350
11
Marcus Grohmann, Florian Wiede, Garron T. Dodd, Esteban N. Gurzov, Geraldine J. Ooi, Tariq Butt, Aliki A. Rasmiena, Supreet Kaur, Twishi Gulati, Pei K. Goh, Aislinn E. Treloar, Stuart Archer, Wendy A. Brown, Mathias Muller, Matthew J. Watt, Osamu Ohara, Catriona A. McLean, Tony Tiganis. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCCCell 2018; 175(5): 1289 doi: 10.1016/j.cell.2018.09.053
12
Yixing Li, Zupeng Luo, Xilong Wu, Jun Zhu, Kai Yu, Yi Jin, Zhiwang Zhang, Shuhong Zhao, Lei Zhou. Proteomic Analyses of Cysteine Redox in High-Fat-Fed and Fasted Mouse Livers: Implications for Liver Metabolic HomeostasisJournal of Proteome Research 2018; 17(1): 129 doi: 10.1021/acs.jproteome.7b00431
13
Seokwon Lee, Younglae Jung, Youngtae Bae, Sung Pil Yun, Suk Kim, Hongjae Jo, Hyung-Il Seo. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in Breast Cancer PatientsTumori Journal 2017; 103(2): 187 doi: 10.5301/tj.5000536
14
Everton Cazzo, Laísa Simakawa Jimenez, Fábio de Felice Gallo, José Carlos Pareja, Elinton Adami Chaim. Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional studySao Paulo Medical Journal 2016; 134(1): 79 doi: 10.1590/1516-3180.2015.01652409
15
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive reviewSao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
16
Kevin M. Hart, Thomas Fabre, Joshua C. Sciurba, Richard L. Gieseck, Lee A. Borthwick, Kevin M. Vannella, Thomas H. Acciani, Rafael de Queiroz Prado, Robert W. Thompson, Sandra White, Genevieve Soucy, Marc Bilodeau, Thirumalai R. Ramalingam, Joseph R. Arron, Naglaa H. Shoukry, Thomas A. Wynn. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-βScience Translational Medicine 2017; 9(396) doi: 10.1126/scitranslmed.aal3694
17
Letícia BALTIERI, Elinton Adami CHAIM, Felipe David Mendonça CHAIM, Murillo Pimentel UTRINI, Martinho Antonio GESTIC, Everton CAZZO. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALSArquivos de Gastroenterologia 2018; 55(3): 247 doi: 10.1590/s0004-2803.201800000-62
18
Natalia Pydyn, Katarzyna Miękus, Jolanta Jura, Jerzy Kotlinowski. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitisPharmacological Reports 2020; 72(1): 1 doi: 10.1007/s43440-019-00020-1
19
Eva M. Dobrindt, Laura Allex, Akylbek Saipbaev, Robert Öllinger, Wenzel Schöning, Johann Pratschke, Dennis Eurich. Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graftClinical Transplantation 2020; 34(12) doi: 10.1111/ctr.14093
20
Christian von Loeffelholz, Johannes Roth, Sina Coldewey, Andreas Birkenfeld. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver DiseaseBiomedicines 2021; 9(12): 1853 doi: 10.3390/biomedicines9121853
21
Srinevas K. Reddy, David A. Geller. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 1065 doi: 10.1016/B978-0-323-34062-5.00071-6
22
Jadine Scragg, Kate Hallsworth, Guy Taylor, Sophie Cassidy, Laura Haigh, Marie Boyle, Quentin Anstee, Stuart McPherson, Leah Avery. Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver diseaseBMJ Open Gastroenterology 2021; 8(1): e000678 doi: 10.1136/bmjgast-2021-000678
23
Yangyang Hui, Binxin Cui, Xiaoyu Wang, Mingyu Sun, Yifan Li, Wanting Yang, Gaoyue Guo, Lihong Mao, Zihan Yu, Xiaofei Fan, Chao Sun. Sarcopenic obesity in liver disease: Handling both sides of the pennyPortal Hypertension & Cirrhosis 2022; 1(1): 42 doi: 10.1002/poh2.10
24
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver diseaseWorld Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
25
Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers, Ger Koek. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2018; 16(6): 837 doi: 10.1016/j.cgh.2017.08.024
26
Della Corte Claudia, Antonella Mosca, Arianna Alterio, Donatella Comparcola, Francesca Ferretti, Valerio Nobili. Pediatric ObesityContemporary Endocrinology 2018; : 451 doi: 10.1007/978-3-319-68192-4_26
27
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and DiagnosisBiomedicines 2021; 9(2): 145 doi: 10.3390/biomedicines9020145
28
Sonja Beckmann, Patrizia Künzler-Heule, Kajetan Kabut, Oliver Mauthner. The Main Thing is to be Alive—Exploring Patients’ Experiences With Weight Gain After Liver Transplantation: A Qualitative StudyTransplant International 2022; 35 doi: 10.3389/ti.2022.10256
29
Akemi Ichikawa, Daiki Miki, C. Nelson Hayes, Yuji Teraoka, Hikaru Nakahara, Chise Tateno, Yuji Ishida, Kazuaki Chayama, Shiro Oka. Multi-omics analysis of a fatty liver model using human hepatocyte chimeric miceScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53890-8
30
Peng Shi, Junru Chen, Jinke Lin, Lurong Zhang. High-throughput fat quantifications of hematoxylin-eosin stained liver histopathological images based on pixel-wise clusteringScience China Information Sciences 2017; 60(9) doi: 10.1007/s11432-016-9018-7
31
Luis Calzadilla‐Bertot, Gary P. Jeffrey, Bryon Jacques, Geoffrey McCaughan, Michael Crawford, Peter Angus, Robert Jones, Edward Gane, Stephen Munn, Graeme Macdonald, Jonathan Fawcett, Alan Wigg, John Chen, Michael Fink, Leon A. Adams. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New ZealandLiver Transplantation 2019; 25(1): 25 doi: 10.1002/lt.25361
32
Namrata Patel, Valentina Discepolo, Nour Asfour, Ruba K. Azzam. Preparedness of Residents to Manage Pediatric Nonalcoholic Fatty Liver Disease: A National SurveyJPGN Reports 2022; 3(3): e219 doi: 10.1097/PG9.0000000000000219
33
Jie Li, Guocai Liu, Feng Zhang, Zhiwen Zhang, Yuqiao Xu, Qing Li. Role of glycoprotein 78 and cidec in hepatic steatosisMolecular Medicine Reports 2017; 16(2): 1871 doi: 10.3892/mmr.2017.6834
34
Lin Fan, Zhen Fu, Yan Xiong, Shaojun Ye, Yanfeng Wang, Guizhu Peng, Qifa Ye. Double‑lobectomy in a steatotic liver transplantation rat modelExperimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9687
35
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
36
Gang Chen, Dongsheng Yu, Xue Nian, Junyi Liu, Ronald J. Koenig, Bin Xu, Liang Sheng. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)Scientific Reports 2016; 6(1) doi: 10.1038/srep35531
37
Wen Su, Zhuo Mao, Yiao Liu, Xiaoyan Zhang, Weizhen Zhang, Jan-Ake Gustafsson, Youfei Guan. Role of HSD17B13 in the liver physiology and pathophysiologyMolecular and Cellular Endocrinology 2019; 489: 119 doi: 10.1016/j.mce.2018.10.014
38
FAN PAN, NAISHUN LIAO, YOUSHI ZHENG, YINGCHAO WANG, YUNZHEN GAO, SEN WANG, YI JIANG, XIAOLONG LIU. Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in ratsMolecular Medicine Reports 2015; 12(3): 3725 doi: 10.3892/mmr.2015.3847
39
Liang Liu, Qinling Hu, Huihui Wu, Xiujing Wang, Chao Gao, Guoxun Chen, Ping Yao, Zhiyong Gong. Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE−/− MiceOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/6256802
40
Harriet Gaskell, Xiaodong Ge, Natalia Nieto. High‐Mobility Group Box‐1 and Liver DiseaseHepatology Communications 2018; 2(9): 1005 doi: 10.1002/hep4.1223
41
Ajay C Donepudi, Gregory J Smith, Oladimeji Aladelokun, Yoojin Lee, Steven J Toro, Marisa Pfohl, Angela L Slitt, Li Wang, Ji-Young Lee, John D Schuetz, José E Manautou. Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic SteatosisToxicological Sciences 2020; 175(2): 301 doi: 10.1093/toxsci/kfaa032
42
Dongxiao Ding, Guozhu Ye, Yi Lin, Yanyang Lu, Han Zhang, Xu Zhang, Zhenyu Hong, Qiansheng Huang, Yulang Chi, Jinsheng Chen, Sijun Dong. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extractsEnvironmental Pollution 2019; 248: 269 doi: 10.1016/j.envpol.2019.01.112
43
Liyang Wang, MengMeng Xu, Odell D. Jones, Zhongguang Li, Yu Liang, Qiuxia Yu, Jiali Li, Yajun Wu, Xinjuan Lei, Boling He, Huimin Yue, Liqin Xiao, Rong Zhou, Wei Zhang, Xin Zhou, Yuhui Zhang, Joseph L. Bryant, Jianjie Ma, Yingli Liu, Xuehong Xu. Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagyCell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00414-2
44
Sara Shojaei Zarghani, Nima Rahimi Kashkooli, Zahra Bagheri, Mahdy Tabatabaei, Mohammad Reza Fattahi, Ali Reza Safarpour. Dietary selenium intake in relation to non-alcoholic fatty liver disease assessed by fatty liver index and hepatic steatosis index; a cross-sectional study on the baseline data of prospective PERSIAN Kavar cohort study.BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01307-4
45
Olfa Khalifa, Khalid Ouararhni, Khaoula Errafii, Nehad M. Alajez, Abdelilah Arredouani. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 CellsInternational Journal of Molecular Sciences 2023; 24(14): 11606 doi: 10.3390/ijms241411606
46
Mahsa Miryan, Mitra Darbandi, Mozhgan Moradi, Farid Najafi, Davood Soleimani, Yahya Pasdar. Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A cross-sectional analysis of the RaNCD cohortFrontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1062008
47
Margaret Morrison, Heather Y. Hughes, Susanna Naggie, Wing-Kin Syn. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?Digestive Diseases and Sciences 2019; 64(12): 3394 doi: 10.1007/s10620-019-05861-7
48
Jadine Scragg, Leah Avery, Sophie Cassidy, Guy Taylor, Laura Haigh, Marie Boyle, Michael I. Trenell, Quentin M. Anstee, Stuart McPherson, Kate Hallsworth. Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver DiseaseClinical and Translational Gastroenterology 2020; 11(9): e00231 doi: 10.14309/ctg.0000000000000231
49
Qi Su, Sun Y. Kim, Funmi Adewale, Ye Zhou, Christina Aldler, Min Ni, Yi Wei, Michael E. Burczynski, Gurinder S. Atwal, Mark W. Sleeman, Andrew J. Murphy, Yurong Xin, Xiping Cheng. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liveriScience 2021; 24(11): 103233 doi: 10.1016/j.isci.2021.103233
50
Lindsay D. Plank, Kylie Russell. Nutrition in liver transplantationCurrent Opinion in Clinical Nutrition and Metabolic Care 2015; 18(5): 501 doi: 10.1097/MCO.0000000000000205
51
Zhipeng Li, Hui Jin, So Young Oh, Geun Eog Ji. Anti-obese effects of two Lactobacilli and two Bifidobacteria on ICR mice fed on a high fat dietBiochemical and Biophysical Research Communications 2016; 480(2): 222 doi: 10.1016/j.bbrc.2016.10.031
52
André Homeyer, Seddik Hammad, Lars Ole Schwen, Uta Dahmen, Henning Höfener, Yan Gao, Steven Dooley, Andrea Schenk. Focused scores enable reliable discrimination of small differences in steatosisDiagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0753-5
53
Giuseppina Pisano, Anna L Fracanzani, Lucio Caccamo, Maria F Donato, Silvia Fargion. Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyWorld Journal of Gastroenterology 2016; 22(40): 8869-8882 doi: 10.3748/wjg.v22.i40.8869
54
Carolyn Ahlers, Matthew Kappus. Obesity management for the pre–liver transplant and post–liver transplant patientClinical Liver Disease 2023; 21(6): 165 doi: 10.1097/CLD.0000000000000039
55
Chongshu Jian, Jiajun Fu, Xu Cheng, Li-Jun Shen, Yan-Xiao Ji, Xiaoming Wang, Shan Pan, Han Tian, Song Tian, Rufang Liao, Kehan Song, Hai-Ping Wang, Xin Zhang, Yibin Wang, Zan Huang, Zhi-Gang She, Xiao-Jing Zhang, Lihua Zhu, Hongliang Li. Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic SteatohepatitisCell Metabolism 2020; 31(5): 892 doi: 10.1016/j.cmet.2020.04.011
56
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCCMetabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
57
Huiling Wu, Xi Song, Yuntao Ling, Jin Zhou, Zhen Tao, Yuying Shen. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver diseaseMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.9931
58
Lili Chen, Qianfei Zhang, Chang Yu, Fang Wang, Xiaoni Kong. Functional roles of CCL5/RANTES in liver diseaseLiver Research 2020; 4(1): 28 doi: 10.1016/j.livres.2020.01.002
59
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, Edgar A. Villavicencio, Rosa M. Vogel, Melanie L. Bell, Yann C. Klimentidis, David G. Marrero, Cynthia A. Thomson. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin AdultsHepatology Communications 2022; 6(6): 1322 doi: 10.1002/hep4.1896
60
Everton Cazzo, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, José Carlos Pareja, Elinton Adami Chaim. Bariatric surgery in individuals with liver cirrhosis: A narrative reviewRevista da Associação Médica Brasileira 2017; 63(2): 190 doi: 10.1590/1806-9282.63.02.190
61
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopyJournal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
62
Diehua Hu, Nadia Primc. Should responsibility be used as a tiebreaker in allocation of deceased donor organs for patients suffering from alcohol-related end-stage liver disease?Medicine, Health Care and Philosophy 2023; 26(2): 243 doi: 10.1007/s11019-023-10141-3
63
Duc-Hung Pham, Changwen Zhang, Chunyue Yin. Using Zebrafish to Model Liver Diseases-Where Do We Stand?Current Pathobiology Reports 2017; 5(2): 207 doi: 10.1007/s40139-017-0141-y
64
Mustafa Oruc, Mustafa Emre Gedik, Meral Uner, Elif Ulug, Reyhan Nergiz Unal, Gurcan Gunaydin, Ahmet Bulent Dogrul. Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosisClinics and Research in Hepatology and Gastroenterology 2024; 48(4): 102314 doi: 10.1016/j.clinre.2024.102314
65
Ivana Mikolasevic, Lidija Orlic, Irena Hrstic, Sandra Milic. Metabolic syndrome and non‐alcoholic fatty liver disease after liver or kidney transplantationHepatology Research 2016; 46(9): 841 doi: 10.1111/hepr.12642
66
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
67
Han Rae Kim, Colin N. Young. Circumventricular organ‐hypothalamic circuit endoplasmic reticulum stress drives hepatic steatosis during obesityObesity 2024; 32(1): 59 doi: 10.1002/oby.23895
68
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation2019; : 279 doi: 10.1007/978-3-319-96400-3_17
69
Fan Lin, Fu Zhen, Xiong Yan, Ye Shaojun, Peng Guizhu, Wang Yanfeng, Ye Qifa. Hypothermic oxygenated perfusion with defatting cocktail further improves steatotic liver grafts in a transplantation rat modelArtificial Organs 2021; 45(9) doi: 10.1111/aor.13976
70
Preethi Chandrasekaran, Ralf Weiskirchen. The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver DiseaseLivers 2023; 4(1): 1 doi: 10.3390/livers4010001
71
André Homeyer, Patrik Nasr, Christiane Engel, Stergios Kechagias, Peter Lundberg, Mattias Ekstedt, Henning Kost, Nick Weiss, Tim Palmer, Horst Karl Hahn, Darren Treanor, Claes Lundström. Automated quantification of steatosis: agreement with stereological point countingDiagnostic Pathology 2017; 12(1) doi: 10.1186/s13000-017-0671-y
72
NAISHUN LIAO, FAN PAN, YINGCHAO WANG, YOUSHI ZHENG, BO XU, WENWEI CHEN, YUNZHEN GAO, ZHIXIONG CAI, XIAOLONG LIU, JINGFENG LIU. Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo studyInternational Journal of Molecular Medicine 2016; 37(5): 1389 doi: 10.3892/ijmm.2016.2528
73
Manuel Manzano, Maria D. Giron, Rafael Salto, Jose D. Vilchez, Francisco J. Reche-Perez, Elena Cabrera, Azahara Linares-Pérez, Julio Plaza-Díaz, Francisco Javier Ruiz-Ojeda, Angel Gil, Ricardo Rueda, Jose M. López-Pedrosa. Quality More Than Quantity: The Use of Carbohydrates in High-Fat Diets to Tackle Obesity in Growing RatsFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.809865
74
Emma Hymel, Elizabeth Vlock, Kurt W. Fisher, Paraskevi A. Farazi, Marcia B. Aguila. Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese micePLOS ONE 2022; 17(8): e0272623 doi: 10.1371/journal.pone.0272623
75
Katia P. Souto, Nelson G. Meinhardt, Maurício J. Ramos, Jane M. Ulbrich-Kulkzynski, Airton T. Stein, Daniel C. Damin. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature reviewSurgery for Obesity and Related Diseases 2018; 14(1): 66 doi: 10.1016/j.soard.2017.09.527
76
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomesCancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
77
Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical PracticeCurrent Gastroenterology Reports 2023; 25(10): 213 doi: 10.1007/s11894-023-00883-8
78
Gregory H. Norris, Christopher N. Blesso. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver diseaseNutrition Reviews 2017; 75(4): 274 doi: 10.1093/nutrit/nux004
79
Sunjae Lee, Cheng Zhang, Zhengtao Liu, Martina Klevstig, Bani Mukhopadhyay, Mattias Bergentall, Resat Cinar, Marcus Ståhlman, Natasha Sikanic, Joshua K Park, Sumit Deshmukh, Azadeh M Harzandi, Tim Kuijpers, Morten Grøtli, Simon J Elsässer, Brian D Piening, Michael Snyder, Ulf Smith, Jens Nielsen, Fredrik Bäckhed, George Kunos, Mathias Uhlen, Jan Boren, Adil Mardinoglu. Network analyses identify liver‐specific targets for treating liver diseasesMolecular Systems Biology 2017; 13(8) doi: 10.15252/msb.20177703
80
Miguel Jiménez-Pérez, Rocío González-Grande, Edith Omonte Guzmán, Víctor Amo Trillo, Juan Miguel Rodrigo López. Metabolic complications in liver transplant recipientsWorld Journal of Gastroenterology 2016; 22(28): 6416-6423 doi: 10.3748/wjg.v22.i28.6416
81
Milad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, Siavash Mansouri, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trialBMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2465-0
82
Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. Treatment of NAFLD with diet, physical activity and exerciseJournal of Hepatology 2017; 67(4): 829 doi: 10.1016/j.jhep.2017.05.016
83
Aiman Obed, Abdalla Bashir, Anwar Jarrad. First right lobe living-donor hepatectomy after sleeve gastrectomyBMC Surgery 2018; 18(1) doi: 10.1186/s12893-018-0366-7
84
Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luís Porrero, María Teresa Alonso, Oscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo, Sol Villar, Alicia Sáez, Javier Rodríguez de Cía, Elvira del Pozo, Lorena Vega‐Piris, Susana Soto‐Fernández, Oreste Lo Iacono, María Eugenia Miquilena‐Colina. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstonesLiver International 2015; 35(8): 1983 doi: 10.1111/liv.12813
85
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Gil F Salles, Cristiane A Villela-Nogueira. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspringWorld Journal of Gastroenterology 2022; 28(25): 2890-2899 doi: 10.3748/wjg.v28.i25.2890
86
Yasar Colak, Ender M. Coskunpinar, Ebubekir Senates, Yasemin Musteri Oltulu, Ilhan Yaylim, Ozlem Kurnaz Gomleksiz, N. Ozan Tiryakioglu, Burcu Hasturk, Cumhur Gokhan Ekmekci, Hulya Yilmaz Aydogan. Assessment of the rs2645424 C/T single nucleotide polymorphisms in the FDFT1 gene, hepatic expression, and serum concentration of the FDFT in patients with nonalcoholic fatty liver diseaseMeta Gene 2018; 18: 46 doi: 10.1016/j.mgene.2018.07.006